COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS
Position in NBIX — Neurocrine Biosciences Inc
CIK 1083190
HARRISBURG, PA
Position in NBIX
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$4,057,094
+$744,360 QoQ
Shares Held
24,072
-4.3% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#234
of 768 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS holds $32,578,099 across 17 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (12.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
10,162 | $5,506,076 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
142,319 | $4,821,767 | |
| 3 | VTRS |
Viatris Inc
|
257,218 | $4,084,621 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
This page
|
24,072 | $4,057,094 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
119,570 | $2,942,617 | |
| 6 | ALKS |
Alkermes plc.
|
39,525 | $2,070,912 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
50,736 | $1,759,017 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
15,587 | $1,729,221 |
All Filings in NBIX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,057,094 | 24,072 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $3,312,734 | 25,146 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $3,538,800 | 24,951 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $3,573,372 | 25,455 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,195,919 | 25,427 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $2,635,929 | 23,833 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $3,052,276 | 22,361 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $2,564,566 | 22,258 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $3,070,867 | 22,306 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $3,035,895 | 22,012 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $2,856,556 | 21,680 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $2,224,687 | 19,775 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $4,447,848 | 47,167 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $4,403,474 | 43,504 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $5,165,421 | 43,247 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,027,376 | 37,919 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,688,350 | 37,837 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,259,500 | 34,768 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,678,852 | 31,453 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,998,913 | 31,268 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $3,065,288 | 31,497 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $3,047,912 | 31,341 | Shares | Sole | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||